Leader Speak Series – Conversation on Healthcare & Health Research

Special guests includes:

  • Anthony Fauci, Director of National Institute of Allergy and Infectious Diseases (NIAID)
  • Dr. Carolyn M. Clancy, Director of Agency for Healthcare Research and Quality (AHRQ)
Advertisements

Leader Speak Series – Healthcare and Health Research: What does the future holds for the federally funded healthcare and health research?

Special guests includes:

  • Anthony Fauci, Director of National Institute of Allergy and Infectious Diseases (NIAID)
  • Dr. Carolyn M. Clancy, Director of Agency for Healthcare Research and Quality (AHRQ)

Dr. Carolyn M. Clancy, Director of Agency for Healthcare Research and Quality (AHRQ), discusses Comparative Effectiveness Research in the Leader Speak Series

Leaders Speak – Special Edition Part III. Discussion on career in Public Service.  Special guests includes:

  • Rob Carey, Department of the Navy Chief Information Officer
  • Ambassador Patrick F. Kennedy, Under Secretary of U.S. Department of State
  • Anthony Fauci, Director of National Institute of Allergy and Infectious Diseases (NIAID)
  • Dr. Carolyn M. Clancy, Director of Agency for Healthcare Research and Quality (AHRQ)
  • Admiral Thad W. Allen, Commandant of the United States Coast Guard
  • Clay Johnson III, formal Deputy Director for Management U.S. Office of management and Budget
  • Tim Cain, formal Governor of Virginia

Leaders Speak – Special Edition Part II. Discussion on what makes an effective Leader and why pursue a career in Public Service.  Special guests includes:

  • Rob Carey, Department of the Navy Chief Information Officer
  • Ambassador Patrick F. Kennedy, Under Secretary of U.S. Department of State
  • Anthony Fauci, Director of National Institute of Allergy and Infectious Diseases (NIAID)
  • Dr. Carolyn M. Clancy, Director of Agency for Healthcare Research and Quality (AHRQ)

With all of the investments discussed today, learn what the steps to insure the public is getting value from these public investments.

The 2009 American Recovery and Reinvestment Act allocated about 1.1 billion dollars for comparative effectiveness research, with some $300,000,000 dedicated to the agency. Learn what Comparative Effectiveness Research is and what AHRQ’s role is in pursuing this research and the priority conditions undergoing such research.